CORD-19:f1fd5f33dcbe0aae1ce2efb7b7d22eafb4247f02 / 20684-20795 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/f1fd5f33dcbe0aae1ce2efb7b7d22eafb4247f02","sourcedb":"CORD-19","sourceid":"f1fd5f33dcbe0aae1ce2efb7b7d22eafb4247f02","text":"Further, blocking IL-4 or IL-13 with neutralizing antibodies restored TLR2 expression and IL-6 production (51).","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T114","span":{"begin":0,"end":111},"obj":"Sentence"}],"attributes":[{"subj":"T114","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T114","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T114","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#ecc893","default":true},{"id":"CORD-19-Sentences","color":"#ae93ec"}]}]}}